Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Microbot Medical's operating assets for the quarter that ended in Mar. 2026 was €4.82 Mil. Microbot Medical's operating liabilities for the quarter that ended in Mar. 2026 was €2.65 Mil. Microbot Medical's Total Assets for the quarter that ended in Dec. 2025 was €69.64 Mil. Therefore, Microbot Medical's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.03.
Microbot Medical Scaled Net Operating Assets Related Terms
Microbot Medical Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Microbot Medical's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microbot Medical Scaled Net Operating Assets Chart
FRA:CY9D vs STXS, POCI, DXR: Scaled Net Operating Assets Comparison
For the Medical Instruments & Supplies subindustry, Microbot Medical's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Microbot Medical Scaled Net Operating Assets vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Microbot Medical's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.03 mean?
Microbot Medical (FRA:CY9D) has a Scaled Net Operating Assets of 0.03 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Microbot Medical and its competitors.
Is Microbot Medical's Scaled Net Operating Assets too high?
Microbot Medical's current Scaled Net Operating Assets is 0.03. Overall, Microbot Medical has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Microbot Medical's Scaled Net Operating Assets compare to STXS and POCI?
Microbot Medical's Scaled Net Operating Assets of 0.03 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Devices & Instruments company?
A good Scaled Net Operating Assets depends on the Medical Devices & Instruments industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Microbot Medical and its competitors. Microbot Medical's current Scaled Net Operating Assets is 0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbot Medical stock overvalued right now?
Microbot Medical (FRA:CY9D) has a current Scaled Net Operating Assets of 0.03. The current Scaled Net Operating Assets is 0.03. Microbot Medical's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Microbot Medical (FRA:CY9D), the current Scaled Net Operating Assets is 0.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
36GF Score
Get the complete analysis for FRA:CY9D
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:CY9D has been successfully added to your 
